Tonix Pharmaceuticals Holding - TNXP Net Assets per Single Share

Graphic logo of Tonix Pharmaceuticals (TNXP)

Tonix Pharmaceuticals (TNXP) develops advanced vaccines and small molecules for the treatment of CNS diseases and infections, leveraging a robust scientific foundation. Stability of raw material supplies is ensured through an extensive network of global routes, eliminating the risk of shortages. The price trend featuring the 13.27 metric demonstrates market dynamics, while multi-year trials and strict government oversight create significant barriers to entry.

Tonix Pharma (TNXP): Share Book Value from 07/04/2022 to 10/28/2026
Manufactured products of Tonix Pharmaceuticals Holding Corp.

The book value per share reflects the net assets of Tonix Pharmaceuticals (TNXP) minus all liabilities, determining the actual value of a single security from a capital perspective. By analyzing the book value per share, an investor can assess the financial stability of Tonix Pharmaceuticals (TNXP) while it conducts costly clinical trials for CNS and immunology therapies, thereby avoiding speculative overpayment for the asset.

Competitors of Tonix Pharmaceuticals (TNXP)

Haleon Group (HLN) - Accounting Value per Share|KVUE: Equity per Share|Net Assets per Single Share Verona Pharma plc (VRNA)|MENS (jyongbio.com) - Share Book Value|Net Assets per Single Share Ligand LGND|Share Book Value Amneal Pharmaceuticals, Inc.|Perrigo Company (PRGO) - Book Value per Share|Accounting Value of a Share Alvotech Biopharmaceuticals (ALVO)|Book Value per Share LQDA (Liquidia Corporation)|glpg.com - Book Value per Share|Net Assets per Single Share ANI Pharmaceuticals, Inc. (ANIP)|MNKD: Accounting Value of a Share|AMPH (Amphastar) - Net Assets per Single Share|Pacira Corp (PCRX) - Accounting Value per Share|SPRY (ARS Pharmaceuticals) - Book Value per Share|Book Value per Share theravance.com (TBPH)|Aquestive Therapeutics, Inc. (AQST) - Accounting Value per Share|Accounting Value of a Share SCPH (scpharmaceuticals.com)|TECX: Net Assets per Single Share|SXTC - Net Asset Value per Share|Accounting Value per Share Eupraxia Pharma EPRX|BHST - Book Price of a Share|Book Value per Share eXoZymes EXOZ|Oramed Pharmaceuticals Inc. (ORMP) - Accounting Value of a Share|Book Value per Share ENTX (Entera Bio Ltd)|Net Asset Value per Share HYFT|ABVC BioPharma (ABVC) - Net Assets per Single Share|Accounting Value of a Share cumberlandpharma.com CPIX|Accounting Value per Share Quantum BioPharma (QNTM)|FibroGen Inc - Book Price of a Share|TELO (Telomir Pharma) - Net Assets per Single Share|RANI: Net Asset Value per Share|Net Assets per Single Share synergychc.com|Rallybio (RLYB) - Equity per Share|LEXX: Book Value per Share|Net Assets per Share Pulmatrix Inc (PULM)|Accounting Value per Share Pheton Holdings Ltd PTHL|Equity per Share aptorumgroup.com APM|Accounting Value per Share Lyra Therapeutics, Inc.|Impact BioMedical, Inc. - Accounting Value of a Share|Net Assets per Single Share TNF Pharma|YCBD - Share Book Value|Book Value per Share PainReform Limited PRFX|Altamira Therapeutics Ltd. (CYTO) - Accounting Value of a Share|LIPO (Lipella Pharmaceuticals) - Book Value per Share|Book Value per Share OPTN|Pieris Pharmaceuticals, Inc. (PIRS) - Net Assets per Single Share|Accounting Value of a Share PROC (Procaps Group)|Petros - Net Assets per Single Share|Accounting Value per Share Qilian International Corp QLI|Acelyrin, Inc. - Book Value per Share|TFFP - Book Value per Share